Lung Function Monitors products

Weakness of the respiratory muscles, most commonly referred as Chronic Obstructive Pulmonary Disease (COPD), is now recognised by the World Health Organiztion (WHO) as the 4th leading cause of worldwide mortality. An international initiative is taking place to raise awareness of this progressing disease. Since the 1960’s when Black and Hyatt first published the original standards for the measurement of respiratory muscle strength, there are today international guidelines such as the ATS/ERS Joint Statement on Respiratory Muscle Testing 2002 and the ERS Monograph 2005 “Respiratory Muscle Assessment”, along with the Global Initiative for Chronic Obstruction Lung Disease (GOLD). The submission of topics is collaborated across a variety of subjects, such as the COPD Exacerbation, Clinical Assessment, Physiotherapy, Pulmonary Rehabilitation, Neuromuscular Disease, Surgical Screening and Physiology.